Hervé Bonnefoi

27.1k citations
135 papers · 5.0k indexed · 1 hit paper · h-index 31

Hervé Bonnefoi

132 papers receiving 4.9k citations

Hit Papers

Identification of molecular apocrine breast tumours by mi...5852005202620122019100200300400500

Peers

Hervé Bonnefoi
Comparison fields: 5 of 120
  • Cancer Research 2.5k
  • Oncology 2.8k
  • Pathology and Forensic Medicine 758
  • Pulmonary and Respiratory Medicine 994
  • Molecular Biology 1.6k
Replace Dongxia Gao with:
Dongxia Gao Canada
Pär‐Ola Bendahl Sweden
Margaretha Rudas Austria
Rosella Silvestrini Italy
Bjørn Naume Norway
Caroline Speers Canada
Aron Goldhirsch Italy
Robert Mennel United States
Rinat Yerushalmi Israel
Thomas Hatschek Sweden
Hervé Bonnefoi relative to Dongxia Gao Canada Dongxia Gao's profile →
Citations per field
00.5×1.5×
Dongxia Gao · 1×
Citations per year

Countries citing papers authored by Hervé Bonnefoi

Since Specialization
Citations

This map shows the geographic impact of Hervé Bonnefoi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hervé Bonnefoi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hervé Bonnefoi more than expected).

Fields of papers citing papers by Hervé Bonnefoi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hervé Bonnefoi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hervé Bonnefoi. The network helps show where Hervé Bonnefoi may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Hervé Bonnefoi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Hervé Bonnefoi Line = papers co-authored together Hervé Bonnefoi links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20227
2 20228
3 202123
4 20213
5 20205
6 201913
7 201932
8 201819
9 20181
10 201787
11 201628
12 201523
13 201456
14 201334
15 2012102
16 201213
17 20102
18 200560
19 20028
20 199622

About Hervé Bonnefoi

Hervé Bonnefoi is a scholar working on Cancer Research, Oncology and Pulmonary and Respiratory Medicine, having authored 135 papers that have together received 5.0k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (62 papers), Advanced Breast Cancer Therapies (34 papers), Cancer Treatment and Pharmacology (34 papers), HER2/EGFR in Cancer Research (33 papers), Cancer Genomics and Diagnostics (25 papers), Breast Lesions and Carcinomas (16 papers), Estrogen and related hormone effects (13 papers) and Cancer Cells and Metastasis (12 papers). The work is most often cited by research in Cancer Research (2.5k citations), Oncology (2.8k citations) and Pathology and Forensic Medicine (758 citations). Hervé Bonnefoi has collaborated with scholars based in France, Switzerland and Belgium. Frequent co-authors include Gaëtan MacGrogan, David Cameron, Richard Iggo, Jonas Bergh, Véronique Becette, Mauro Delorenzi, Pierre Farmer, Craig Underhill, Maud Toulmonde and P. Fumoleau. Their work appears in journals such as Nature Medicine, Journal of Clinical Oncology and Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026